This inventor holds 1 USPTO granted patent. Top assignees: Bar-Ilan University, Eybna Technologies Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 246 
1 out of 1 Years Active: 2026
Title: Amnon Albeck: Innovator in THC Derivatives
Introduction
Amnon Albeck is a notable inventor based in Gimzo, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of THC derivatives. His work focuses on oral dosage forms that can be used to treat various diseases and disorders.
Latest Patents
Amnon Albeck holds a patent for "THC derivatives, oral dosage forms comprising same, uses thereof for treating diseases and disorders and synthesis thereof." This patent outlines the formulations, synthesis, and applications of THC derivatives for oral administration, aimed at treating a range of medical conditions.
Career Highlights
Throughout his career, Amnon has worked with esteemed institutions such as Bar-Ilan University and Eybna Technologies Ltd. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Amnon has collaborated with notable individuals in his field, including Jacob Wolfman and Nadav Eyal. These partnerships have further enriched his work and expanded the impact of his innovations.
Conclusion
Amnon Albeck's contributions to the field of THC derivatives highlight his role as an innovator in pharmaceutical research. His patent and collaborations reflect his commitment to advancing medical treatments through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile